Skip to main content
Premium Trial:

Request an Annual Quote

IDBS Expands US Headquarters to Include Healthcare Center of Excellence


This week, IDBS expanded its office in Burlington, Mass., to include a Healthcare Center of Excellence to support its efforts on the translational medicine front.

The center is expected to support IDBS' personalized medicine activities through collaborations with the local and international health science ecosystem, the company said.

The company opened a US-based headquarters for its healthcare business last July and added 22 full-time employees to better serve its customers in the space.

At the time, IDBS' Founder and CEO Neil Kipling said that the Burlington office was "a natural US hub" for company pursuits in the translational medicine market, and that the concentration of clinical research efforts, life sciences research and development, and industrial-academic collaborations provided "an ideal environment to expand our R&D business and to create our US Center of Excellence for Healthcare."

The company has existing relationships with the Dana-Farber Cancer Institute, Selventa, Merck, Biogen, Shire, and Novartis, among other life sciences groups that are located in the region.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.